Viewing Study NCT06526104


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-01-22 @ 9:14 AM
Study NCT ID: NCT06526104
Status: RECRUITING
Last Update Posted: 2024-12-09
First Post: 2024-07-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas with Child-Pugh-B Cirrhosis
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module